james q. del rosso, do - what lab monitoring do you recommend for patients starting dupilumab?
Published 3 years ago • 10 plays • Length 1:28
Download video MP4
Download video MP3
Similar videos
-
1:04
james q. del rosso, do - do you support dupilumab for all of the ad spectrum conditions if...
-
2:07
james q. del rosso, do - what are the recommendations on how to monitor patients on oral jak...
-
1:09
james q. del rosso, do - do you need to monitor any laboratory testing with topical jak inhibitors?
-
1:16
james del rosso, do - are there issues with ruxolitinib in patients using dupilumab or tralokinumab?
-
1:03
james q. del rosso - what's new in the medicine chest part 1
-
4:14
what's new in the medicine chest, part i: james q. del rosso, md
-
4:19
james q. del rosso, do - association between rosacea, environmental factors, and facial cutaneous...
-
2:02
james q. del rosso, do - can dupilumab cause cutaneous t-cell lymphoma (ctcl)?
-
7:00
eczema results: before-and-after dupixent | see bit.ly/dupixentpi
-
2:51
dupixent self injections at home! don’t worry, you will be okay!
-
26:21
dupixent® (dupilumab) pre-filled pen supplemental injection training
-
1:34
james del rosso, do - given the options, when do you consider ruxolitinib for atopic dermatitis?
-
2:13
what's new in the medicine chest? part ii. james q. del rosso, do
-
4:58
james q. del rosso, do - psoriasis therapy beyond biologics
-
1:20
james q. del rosso, do - can amzeeq be combined with benzoyl peroxide?
-
2:13
what's the most common side effect of dupixent?
-
1:04
james del rosso, do - do you ever need to perform a skin biopsy on patients with atopic dermatitis?
-
14:20
digital highlights hub | dr james del rosso
-
1:21
james del rosso, do - what other diagnoses can be confused with atopic dermatitis?
-
3:28
managing atopic dermatitis with dupilumab: what you need to know
-
1:39
fc21 - what's new in skin, the journal of cutaneous medicine, james q. del rosso, do
-
1:21
james q. del rosso, do - do you see winlevi replacing aczone?
Clip.africa.com - Privacy-policy